Clinical trial
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
NCT02048241 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit disorder, childhood aggression, intermittent explosive disorder, oppositional defiant disorder